Friday, April 16, 2021

VIVIMEDLAB | Stock Analysis and Price Outlook

 

Vivimed Labs Ltd.

Stock/Share Price: 19.75


➽ Vivimed Labs Ltd is engaged in manufacturing specialty chemicals and cosmetic ingredients like Triclosan, Avis etc. catering to global and domestic markets.The product range of the company includes Triclosan VIV 20,Avis (Avo benzone),NDGA (Anti-oxidant),Hair care,Oral care,Anti microbial,Calcium Glycero Phosphate (CaGP),etc..The company also engagged in the business of Pharmaceuticals, Speciality Chemicals.


Key  Summary


Promoters pledge remained unchanged at 60.09% of holdings in Dec 2020 qtr.

Promoters holding remains unchanged at 32.79% in Dec 2020 qtr

FII/FPI holding remains unchanged at 3.1% in Dec 2020 qtr

Number of FII/FPI investors remains unchanged at 11 in Dec 2020 qtr

Institutional Investors holding remains unchanged at 3.22% in Dec 2020 qtr




Financial Data Highlights

Market Cap163.34
Book Value/ Share61.244
Enterprise Value31.00
Revenue TTM1068.76
Gross Profit TTM581.66
Revenue /Share TTM128.94
Consensus Target134.00


Technical Chart & Price Outlook



Stock break an important neckline with good volume in todays session.
Long position can be made for the levels of 28 / 34 in short to mid term time period.



Recent Valuation Summary


Stock gained more than 20% in one month

Strong Momentum: Price above short, medium and long term moving averages

TTM PE Ratio - Negative PE Trailing 12M

Market Cap - Below industry Median

Price to Book Ratio - Low in industry

TTM PEG Ratio - Below industry Median


Apollohosp | Stock Price Outlook


Thanks for your Precious Time.


Finvest Online
Telegram  :  t.me/finvestonline






Disclaime
r- The information on this blog are based on my personal opinion and experience, it should not be considered professional financial investment advice and in no way it should be considered as a tip. We does not take any compensation of any kind whatsoever from any reader,user and company that are mention on this website.We are not SEBI registered financial advisor or analyst.


No comments:

Post a Comment